by referring initially to remarks about the structure and function of the coagulation factor viii and about the manufacture and demand for preparations for the substitution treatment in patients affected with haemophilia a , possibilities are presented how to increase the collection of factor viii by applying intensive measures .
C0019069
haemophilia a
C0015506
factor viii